Kopran Ltd

Kopran Investor Presentation: Key Takeaways

Kopran Q2 FY27 consolidated revenue ₹21,126 Lakh (+79% YoY), EBITDA ₹1,822 Lakh (8.62%), PAT ₹439 Lakh vs prior-year loss; borrowings up.

Kopran Q2 FY27 Results: Turns Profitable, Net Profit ₹4.4 Cr

Kopran Ltd reported revenue from operations of ₹211.3 Cr (+79.2% YoY) and net profit of ₹4.4 Cr for Q2 FY27.

Key figure

Net profit ₹4.4 Cr

Kopran Board Meeting Date

Kopran Ltd intimates a board meeting on November 3, 2026, to consider and approve Q2 FY27 unaudited financial results. No financial figures are disclosed in this advance notice.

Kopran Business Update

Kopran's Khopoli formulation facility concluded an EU GMP inspection with no critical or data-integrity observations. The company will submit compliance responses for one major and minor findings within two weeks.

Kopran Other Announcement

Kopran Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.

Kopran Promoter Buying

Sarvamangal Mercantile Company Limited acquired 170,000 shares of Kopran Ltd through market purchases. The transaction increases the promoter group's stake in the target company by 0.35%.

Promoter stake change

+0.35%

Kopran Price Movement Clarification

Kopran Limited responded to NSE's price-movement query stating no material information was withheld. The stock's rise is attributed to purely market-driven forces.

Kopran Employee Stock Options

Kopran Limited allotted 40,500 equity shares to employees under its ESOP 2023 scheme. The exercise price for these shares is Rs 179 per share.

Value

₹0.72 Cr

Kopran Promoter Selling

United Shippers, a promoter of Kopran, sold 12,00,000 shares in the open market on 07 Sept 2026. Its stake fell from 4.56% to 2.07%.

Kopran Price Movement Clarification

Kopran Limited clarified to NSE that the recent increase in trading volume is purely market-driven. The company confirmed it has not withheld any material price-sensitive information.

Kopran Annual General Meeting

Kopran Ltd held its 67th Annual General Meeting on August 18, 2026, where all items were passed. Voting results and the Scrutinizer's Report were submitted.

Kopran Investor Presentation: Key Takeaways

Kopran Ltd reported Q1 FY27 revenue of ₹15,399 Lakhs with a 10.31% EBITDA margin, focusing on API and Formulation verticals across 50+ nations.

Kopran Q1 FY27 Results: Net Profit ₹6.7 Cr, Down 9.5% YoY

Kopran Ltd reported revenue from operations of ₹154 Cr (+13.9% YoY) and net profit of ₹6.7 Cr (-9.5% YoY) for Q1 FY27.

Key figure

Net profit ₹6.7 Cr · -9.5% YoY

Kopran Annual Report

Kopran Ltd has submitted its Annual Report for FY 2025-26, including the notice of its 67th Annual General Meeting scheduled for August 18, 2026.

Kopran Board Meeting Date

Kopran Ltd has scheduled a board meeting for August 07, 2026, to consider and approve its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Kopran Dividend

Kopran Limited fixed August 11, 2026, as the record date for dividend payments. The dividend is subject to approval at the AGM scheduled for August 18, 2026.

Kopran Management Change

Kopran Limited appointed Mr. Vijay L Thange as Chief Technical Officer. He brings over 36 years of experience in the pharma sector.

Kopran Acquisition

Kopran Limited shareholders and creditors approved the Scheme of Amalgamation with Kopran Laboratories Limited. The resolution passed with requisite majority during the NCLT-convened meetings.

Kopran Other Announcement

Kopran Ltd submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory adherence with no significant non-compliances.

Kopran Dividend

Kopran Limited recommended a final dividend of ₹3 per equity share for FY 2025-26. Shareholders will vote for approval at the upcoming August 18 general meeting.

Kopran Earnings Call: Key Takeaways

Kopran Ltd reported highest-ever quarterly revenue of ₹23,402 lakhs and EBITDA of ₹4,057 lakhs in Q4-FY26, driven by strong growth in APIs and Formulations.

Kopran Management Change

Kopran Limited appointed Mrs. Namrata Varun Somani as a Non-Executive Director for five years. This strategic board addition strengthens leadership and brings legal expertise.

Execution

60 months

Kopran Q4 FY26 Results: Net Profit ₹18.9 Cr, Up 94.8% YoY

Kopran Ltd reported revenue from operations of ₹234 Cr (+35.7% YoY) and net profit of ₹18.9 Cr (+94.8% YoY) for Q4 FY26.

Key figure

Net profit ₹18.9 Cr · +94.8% YoY

Kopran Financial Results

Kopran Limited reported audited FY2026 financial results and recommended a ₹3.00 per share dividend. The board also appointed Namrata Somani as a non-executive promoter group director.

Value

₹3.00 Cr

Kopran Fund Raise of ₹18.75 Cr

Kopran's subsidiary KRLL will raise ₹18.75 Crore through a 1:12 rights issue. Proceeds will fund working capital requirements, strengthening the subsidiary's operational liquidity.

Value

₹18.75 Cr

Kopran Annual General Meeting

Kopran Limited announced an NCLT-convened meeting on June 3, 2026, to approve the amalgamation of Kopran Laboratories Limited into the company. The merger will increase promoter shareholding from 44.43% to 55.33%. This consolidation aims to streamline the group structure and enhance operational efficiencies in the pharmaceutical and healthcare segments.

Kopran Board Meeting Date

Kopran Ltd has scheduled a Board Meeting on May 19, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a dividend. The trading window for company securities remains closed until 48 hours after the results declaration.

Kopran Acquisition

Kopran Limited announced meetings for shareholders and creditors on June 03, 2026, to approve the merger by absorption of Kopran Laboratories Limited. The amalgamation is pursuant to an NCLT Mumbai Bench order dated April 09, 2026. This consolidation aims to merge the transferor entity into the transferee company.

Kopran Q3 FY26 Results: Net Profit ₹9.3 Cr, Down 10.6% YoY

Kopran Ltd reported net profit of ₹9.3 Cr (-10.6% YoY) for Q3 FY26.

Key figure

Net profit ₹9.3 Cr · -10.6% YoY

Kopran Legal & Regulatory

Kopran Limited received an NCLT order dated April 09, 2026, directing the company to hold meetings for Equity Shareholders, Secured Creditors, and Unsecured Creditors. This update relates to the ongoing Scheme of Amalgamation of Kopran Laboratories Limited with Kopran Limited.